Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03085433 · ClinicalTrials.gov registry record · NA

Sperm Selection by Microfluidic Separation Improves Embryo Quality

A NA study of Infertility and Infertility, Male, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
393
Enrollment target
1
Study location

NCT03085433 is a NA study of Infertility and Infertility, Male that has completed, run by University of California, San Francisco. The registered enrollment target is 393 participants, below the 7,584-participant average among 74 other Infertility trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03085433, a NA study of Infertility and Infertility, Male, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
393 participants
Enrollment target
1
Study location

Study Summary

This is a randomized controlled trial of couples with a history of poor embryo quality undergoing a repeat in vitro fertilization (IVF) cycle for unexplained infertility. Couples will be randomized to sperm selection by the clinical standard of centrifugation and density-gradient processing compared to the microfluidic sperm sorting chip.

Interventions

  • DEVICE Microfluidic Sperm Sorting
  • PROCEDURE in vitro fertilization

Study Locations (1)

California

  • University of California San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 393 participants
Start Date 2017-06-20
Est. Completion 2022-04-30
Phase NA

What the Registry Record Tells You About NCT03085433

The ClinicalTrials.gov registry entry for NCT03085433 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 393 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,584-participant average among 74 other Infertility trials with a reported enrollment target (95% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Infertility appearing as the primary indexed condition, and to 2 interventions - of which Microfluidic Sperm Sorting is the first listed.

NCT03085433 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03085433 about?

NCT03085433 is a clinical study titled "Sperm Selection by Microfluidic Separation Improves Embryo Quality". This is a randomized controlled trial of couples with a history of poor embryo quality undergoing a repeat in vitro fertilization (IVF) cycle for unexplained infertility. Couples will be randomized to sperm selection by the clinical standard of centrifugation and density-gradient processing compared...

What is the current status of trial NCT03085433?

This trial is currently completed. It is a NA study. The enrollment target is 393 participants. The study started on 2017-06-20. Estimated completion is 2022-04-30.

What conditions does trial NCT03085433 study?

This clinical trial studies the following conditions: Infertility, Infertility, Male, Fertility Disorders, Sperm DNA Fragmentation, Infertility Unexplained.

What interventions are being tested in trial NCT03085433?

The interventions under investigation include: Microfluidic Sperm Sorting (DEVICE), in vitro fertilization (PROCEDURE).

Who is sponsoring clinical trial NCT03085433?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03085433 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.